Intuitive Surgical, Inc. $ISRG Stock Position Raised by Wedmont Private Capital

Wedmont Private Capital boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,163 shares of the medical equipment provider’s stock after purchasing an additional 2,785 shares during the period. Wedmont Private Capital’s holdings in Intuitive Surgical were worth $3,391,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Connecticut Wealth Management LLC raised its stake in shares of Intuitive Surgical by 1.8% in the fourth quarter. Connecticut Wealth Management LLC now owns 1,308 shares of the medical equipment provider’s stock valued at $741,000 after acquiring an additional 23 shares during the last quarter. 3Chopt Investment Partners LLC grew its position in Intuitive Surgical by 5.2% during the 1st quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock worth $213,000 after acquiring an additional 23 shares during the last quarter. Vermillion Wealth Management Inc. grew its position in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its holdings in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after purchasing an additional 25 shares in the last quarter. Finally, Blue Fin Capital Inc. raised its position in Intuitive Surgical by 0.5% in the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after purchasing an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays upgraded Intuitive Surgical to “strong buy” and initiated coverage at “overweight,” citing the company’s high-quality healthcare-equipment business despite a softer medical-device market. The bullish rating provides a near-term catalyst for the shares. Barclays initiates coverage of Intuitive Surgical
• Positive Sentiment: Piper Sandler also assigned a Buy rating, reinforcing favorable sell-side sentiment around ISRG. Intuitive Surgical gets a Buy from Piper Sandler
• Positive Sentiment: The company’s single-port robotic platform is gaining momentum, with rising procedures, utilization and system placements. Expanding medical indications and international adoption could support longer-term revenue growth. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts’ average recommendation remains bullish, but commentary warns that consensus ratings can be overly optimistic and that ISRG’s valuation leaves limited room for disappointment. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Neutral Sentiment: A reported short-interest figure of zero shares and a zero-day days-to-cover ratio suggests the latest short-interest data may be incomplete or erroneous, limiting its usefulness as a trading signal.
• Negative Sentiment: Jim Cramer expressed concern that Johnson & Johnson and other rivals could intensify competition in robotic surgery, potentially pressuring ISRG’s long-term market position. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $423.96 on Friday. The stock has a fifty day moving average of $386.36 and a 200-day moving average of $411.26. The stock has a market capitalization of $149.78 billion, a P/E ratio of 48.56, a price-to-earnings-growth ratio of 3.13 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.81 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Leerink Partners reduced their price objective on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Bank of America cut their price target on Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, September 20th. Oppenheimer raised shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price objective on the stock in a report on Wednesday, August 12th. Finally, Barclays upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $502.53.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the transaction, the vice president directly owned 1,026 shares in the company, valued at $384,175.44. This trade represents a 51.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,370 shares of company stock worth $4,891,989. Corporate insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.